What are the causes of viral hemorrhagic fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Viral Hemorrhagic Fever

Viral hemorrhagic fevers are caused by enveloped RNA viruses from four main families: Arenaviridae (e.g., Lassa virus), Filoviridae (e.g., Ebola virus), Flaviviridae (e.g., yellow fever, dengue), and the order Bunyavirales (e.g., Crimean-Congo hemorrhagic fever, hantaviruses). 1, 2

Viral Families and Specific Pathogens

Arenaviridae

  • Lassa virus: The most clinically significant arenavirus, endemic in West Africa with an estimated 300,000-500,000 cases yearly 1
  • Junin and Machupo viruses: South American hemorrhagic fever viruses 1

Filoviridae

  • Ebola virus: Causes severe VHF with high mortality, responsible for major outbreaks in Africa 3
  • Other filoviruses within this family 2

Flaviviridae

  • Yellow fever virus: Causes VHF with similar molecular pathogenesis to other VHF agents 4
  • Dengue virus: The most common cause of VHF in returning travelers, accounting for 5.2% of febrile cases (15.9% of tropical diseases) 5

Bunyavirales (formerly Bunyaviridae)

  • Crimean-Congo hemorrhagic fever virus 1
  • Hantaviruses: Cause hemorrhagic fever with renal syndrome 1, 2
  • Other bunyaviruses 6

Transmission Routes

Primary Transmission (Zoonotic)

  • Rodent reservoirs: Lassa virus is transmitted primarily through contact with excreta of Mastomys natalensis rodents 1
  • Vector-borne: Many VHFs involve arthropod vectors in their transmission cycle 2
  • Animal contact: Most VHF viruses are zoonotic, causing asymptomatic infections in their natural hosts but potentially lethal disease in humans 6

Secondary Transmission (Human-to-Human)

  • Direct contact with infected bodily fluids: Blood, saliva, vomit, stool, or urine 1
  • Nosocomial transmission: Well-documented in healthcare facilities, particularly in endemic areas 1
  • Note: Secondary transmission is uncommon but represents a significant risk in healthcare settings 1

Epidemiological Context

The geographic distribution is highly variable, with most VHFs being geographically localized to specific endemic regions 7. In returning travelers presenting with fever, malaria remains the most common tropical infection (22.2% of cases), followed by dengue fever (5.2%), and enteric fever (2.3%), while viral hemorrhagic fevers specifically account for only 0.1% of cases 5. However, the severity and outbreak potential of VHFs make them critical to recognize despite their relative rarity in travelers.

Clinical Pitfalls

Do not rely on hemorrhagic manifestations for diagnosis—VHFs initially present as non-specific febrile illnesses with malaise, fever, and muscle aches that may progress to vascular permeability, coagulopathy, and varying degrees of hemorrhage 2, 6. Early laboratory findings typically show leukopenia, thrombocytopenia, and elevated liver enzymes 2.

References

Research

[Viral hemorrhagic fevers: Pathogenesis, epidemiology and clinical manifestations].

Klinicka mikrobiologie a infekcni lekarstvi, 2025

Research

Viral Hemorrhagic Fever Diagnostics.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

Research

Molecular pathogenesis of viral hemorrhagic fever.

Seminars in immunopathology, 2017

Research

Viral Hemorrhagic Fevers Other than Ebola and Lassa.

Infectious disease clinics of North America, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.